A review of the recent evidence suggests that GLP-1 drugs, such as semaglutide, could protect brain health and cognitive ...

The surge in popularity of drugs like Ozempic, driven in part by its weight loss benefits, is contributing to a record-high ...

AMSTERDAM — Prurigo nodularis (PN), an itchy, highly symptomatic disease that can cause severe impairments in quality of life ...

“Our early data suggests a strong synergistic effect from combining these drugs, resulting in significant cognitive enhancement,” said Maria Maccecchini, Ph.D., Founder, President, and CEO of Annovis ...

a telehealth service that helps users get prescriptions for drugs like Ozempic, Wegovy and Trulicity. Prior to joining WeightWatchers, Sistani co-founded Houseparty, a now-discontinued social ...

The move came after Winfrey told People magazine that she was using a weight-loss medication in December 2023. At the time of her departure, the company said that Winfrey aimed to “eliminate any ...

approved COBENFY (xanomeline and trospium chloride), an oral medication that is manufactured by Bristol Myers Squibb in New Jersey. This marks the first new class of medications for the brain ...

has approved COBENFY™ (xanomeline and trospium chloride), an oral medication for the treatment of schizophrenia in adults. 1 COBENFY represents the first new class of medicine in several decades ...

KarXT will be marketed and sold under the brand name Cobenfy, and it is the first new treatment class drug approved to treat schizophrenia for precisely 35 years — the last being clozapine ...

The drug was developed by Karuna Therapeutics, which was bought by Bristol Myers Squibb (BMS) last year for $14 billion. This is the first new class of treatment for the psychiatric disorder since ...

Spending two hours on hold to her pharmacy or GP each day has become the norm for Lorelei Mathias, 44, who has struggled to get a consistent supply of her prescription ADHD drugs since the ...